We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




MRI Helps Evaluate Potential Living Liver Donors

By HospiMedica International staff writers
Posted on 09 Aug 2017
New magnetic resonance imaging (MRI) contrast agents and pulse sequence techniques can be used to noninvasively evaluate the livers of potential live donors, according to a new review.

Researchers at the University of Toronto (Canada) conducted a review of studies that focusing on the role of state-of-the-art MRI-based techniques in the comprehensive evaluation of living donors in a single-visit. More...
The techniques reviewed include assessment of the liver vasculature via MRI angiography; assessment of the biliary tract via conventional T2-weighted MRI cholangiography and T1-weighted gadoxetate disodium–enhanced MR cholangiography; and evaluation of hepatic steatosis via T2-corrected multiecho chemical shift–based water-fat separation MRI and high-speed T2-corrected multiecho MR spectroscopy (MRS).

Contrast-enhanced MR angiography (MRA), for example, permits hepatic arterial system visualization to the segmental level using gadopentetate dimeglumine as the contrast agent, providing a high signal-to-noise ratio due to its high T1 relaxation rate. Contrast-enhanced MRA has been shown to be as accurate as computerized tomography angiography (CTA) at detecting surgically important anatomic variants of the hepatic vasculature in donor candidates, with accuracy of 86%, 93%, and 68% for the hepatic artery, portal vein, and hepatic vein, respectively.

The increasing use of hepatocyte-specific contrast agent in liver MRI, such as gadobenate dimeglumine and gadoxetic disodium, can accurately display intrahepatic and extrahepatic biliary anatomy. A recent study classified normal and variant biliary systems correctly using a single-dose of gadoxetic disodium enhanced T1-weighted MRC, which could prove an alternative to CT cholangiogram for preoperative evaluation of donor candidates. Other studies show the quality of hepatobiliary phase images obtained using the CAIPIRINHA technique are significantly improved, which could enable gadoxetic disodium–enhanced T1-weighted MRC to provide a better visualization of biliary variants.

MRI techniques can also be used for noninvasive evaluation of hepatic steatosis by separating liver signal into its fat and water signal components first, and then calculating the hepatic fat fraction. MRI-measured hepatic fat fraction, which includes signal fat fraction and proton-density fat fraction, has a strong correlation with histologic grade. The researchers also reviewed MRI and MRS methods used for signal fat fraction and proton-density fat fraction measurement for the evaluation of hepatic steatosis. The review was published in the July 2017 issue of the American Journal of Roentgenology.

“Since the first adult-to-adult transplantation of a right liver lobe reported in 1994, the number of living-donor liver transplants has increased dramatically with good results, similar to those of cadaver liver transplantation,” said lead author Kartik Jhaveri, MD, of the Joint Department of Medical Imaging. “To guide safe harvesting of the graft from donors, an accurate preoperative evaluation of potential living liver donors for conditions that increase the donor's surgical risk is crucial.”

Related Links:
University of Toronto


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Blood Gas Analyzer
i-Check200
Desk Aneroid Sphyg
Diagnostix 750D+
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Credit: MedUni Wien/Houdek

New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation

When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.